Clearstead Advisors’s Apnimed Inc APMD Stock Holding History

Clearstead Advisors’s Portfolio APMD Stock Details APMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.38K	Buy	+200	New	+$5.38K	﹤0.01%	2248

Other funds holding APMD

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Asset Planning Inc Cypress, California $152M AUM 19.47% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Clearstead Advisors's APMD Position: Q3 2026 in Review

Clearstead Advisors opened a new position in Apnimed Inc (APMD) in Q3 2026: 200 shares worth $4.38K. The stake represents ﹤0.01% of the portfolio and ranks #2248 among its holdings.

15 funds tracked by Wall St. Rank hold APMD as of Q3 2026.

Clearstead Advisors held 200 shares of Apnimed Inc worth $4.38K as of Q3 2026.
Apnimed Inc was a new Clearstead Advisors position in Q3 2026.
Apnimed Inc made up ﹤0.01% of Clearstead Advisors's portfolio in Q3 2026, its #2248 holding.
15 funds tracked by Wall St. Rank held Apnimed Inc as of Q3 2026.

Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.